Using and Interpreting Diabetes Data. Irl B. Hirsch, MD University of Washington

Similar documents
Diabetes Technology for the Endocrinologist, Irl B. Hirsch, MD University of Washington

Applications of Technologies to Your Patient. Irl B. Hirsch, MD Professor of Medicine University of Washington School of Medicine Seattle, Washington

Pump and Sensor Data Interpretation. Irl B. Hirsch, MD University of Washington School of Medicine

Diabetes Technology in Irl B. Hirsch, MD University of Washington School of Medicine Seattle, WA

Technology in Diabetes Management Irl B. Hirsch, MD University of Washington

CGM and Closing The Loop

1. Continuous Glucose Monitoring

Incorporating CGM Into Clinical Decision Making. Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA

5/18/2010. History of 1,5 Anhydroglucitol (1,5 AG) Glucose Variability & Pattern Management: Way Beyond Logbooks. Normal Renal Glucose Handling

Glucose Variability & Pattern Management: Way Beyond Logbooks Irl B. Hirsch, M.D. University of Washington, Seattle, WA

Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim

Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)

Update on Diabetes Technology

Insulin Pumps and Continuous Glucose Sensors- Embracing Technology. Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education

The Realities of Technology in Type 1 Diabetes

Advances in Diabetes Care Technologies

NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP

Diabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections. Aaron Michels MD

Continuous Glucose Monitoring (CGM)

CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical

Making Sense of Glucose Monitoring. My Journey with Glucose Monitoring Over the Last 37 Years 8/7/2017

Advances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier?

Making the Most of Continuous Glucose Monitoring

Diabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE

DIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson

Emerging Automated Insulin Delivery Systems

Advances in Diabetes Care Technologies

Dr Sander Zwart MD, FACP, ECNU Arizona-AACE 2016 Annual Meeting

Today s Goals 10/6/2017. New Frontiers in Diabetes Technology. Disclosures

When Will CGM Replace SMBG? Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida

Advances in Diabetes Care Technologies

INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION

Real-Time Continuous Glucose Monitoring: From Application to Evaluation

The Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes

Comparing the use of SMBG vs. CGM data to Optimize Glucose Control in T2DM

OBJECTIVES THE PAST INNOVATIVE TECHNOLOGY & DIABETES DIABETES MIS MANAGEMENT IMPROVEMENTS IN DIABETES MANAGEMENT

Diabetes Technology Update. Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018

Incorporating CGM Into Clinical Decision

Continuous Glucose Monitors for Diabetes Management

PROTOCOL FOR HYBRID CLOSED LOOP TECHNOLOGY

How I use the latest technology to investigate and treat a person with Type 1 Diabetes. Dr Pratik Choudhary

Self-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool

Technology in Diabetes Care: Emerging Level

Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico

Update on Continuous Glucose Monitoring (CGM) Technology in Diabetes. Elena Toschi, MD November 12, 2016

Advances in Diabetes Technology Part II: Analysis of Diabetes Self Management Devices and Support Tools

Updates in Diabetes Technology

Paradigm/Guardian CGM Screens. CareLink Online Reports. Make Your Own Jackson Pollack. CGM by Jackson Pollack. How To Read CGM Screens/Reports

Report Reference Guide. THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1

Interpretation of Continuous Glucose Monitoring (CGM) Data

Case Study: Competitive exercise

Using Insulin in the Primary Care Setting: Interactive Cases

Objectives. The Problem. We ve come a LONG way, Innovations in Diabetes Care and Management. Barbara Walz, RN, BSN, CDE April 26, 2018

Current Glucometers. Junior s s Glucose Log. All have advantages and disadvantages Answer 2

Tips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital

What is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming

CAROLINAS CHAPTER/AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS Annual Meeting HILTON HEAD ISLAND FRIDAY PRESENTATION

Managing Problematic Hypoglycaemia Pratik Choudary

Report Reference Guide

BASICS OF INSULIN PUMPS. Jennifer Okemah MS RD BCADM CDE CSSD

Optimizing Therapy and Clinical Outcomes Using Real-Time Continuous Glucose Monitoring (AADE PRODUCT THEATRE) August 7, 2014 Orlando, FL

CGM: Continuous Glucose Monitoring Making Sense of It All AW: ANCO/GEND/1016/0117

REPORT INTERPRETATION

Basics of Continuous Subcutaneous Insulin Infusion Therapy. Lubna Mirza, MD Norman Endocrinology Associates 2018

Presented by Dr. Bruce Perkins, MD MPH Dr. Michael Riddell, PhD

Flash Glucose Monitoring & Implantable Sensors

Pumps & Sensors made easy. OPADA ALZOHAILI MD FACE Endocrinology Assistant Professor Wayne State University

THE MINIMED 670G SYSTEM SCHOOL NURSE GUIDE

Approved by: Integrated Health Quality Management Subcommittee Effective Date: Department of Origin: Integrated Healthcare Services.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

THERAPY MANAGEMENT SOFTWARE FOR DIABETES

Technology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE

Now you know. InPen MOBILE APP. Healthcare Provider INSTRUCTIONS FOR USE. CompanionMedical.com Companion Medical, Inc.

ssociation of Children s Diabetes Clinicians Clinicians Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients

INSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد

The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections

7/18/2017. Everything discussed in this presentation is off-label. (And that s ok.) Dana Lewis Founder, #OpenAPS WARNING: Disclosure to Participants

DIABETES TECHNOLOGY: ENDLESS CHOICES FOR HEALTHY MANAGEMENT

THERAPY MANAGEMENT SOFTWARE FOR DIABETES

Harvesting Healthy Hemogobins: Optimal Management of A1c and Beyond. Carol H. Wysham, M.D Rockwood Clinic Spokane, WA

ADVANCES IN DIABETES TECHNOLOGY: A FOCUS ON CONTINUOUS GLUCOSE MONITORING 9:15 10:15 AM

COMPANY OVERVIEW. July 30, 2018

10:20 AM March 5, B 100% 235 u. 124 mg/dl 3 HRS INSULIN ON BOARD:

Effective Health Care Program

OneTouch Reveal web app Report Reference Guide

Hypoglycemia a barrier to normoglycemia Are long acting analogues and pumps the answer to the barrier??

Glucometers Gastrostomy Tubes Nasogastric Tubes Insulin pumps Continuous Glucose monitoring system Closed Loop Smart phones/tablets

4/2/2018 MOVING THROUGH PREGNANCY WITH TECHNOLOGY CLINICAL EXPERIENCE WITH PUMPS, CGMS AND THE HYBRID CLOSED LOOP CONFLICT OF INTEREST DISCLOSURE

COMPANY OVERVIEW. April 26, 2018

Live life, less complicated. InPen MOBILE APP. Healthcare Provider INSTRUCTIONS FOR USE. CompanionMedical.com

QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?

Diabetes Management: Current High Tech Innovations

Company Overview February 26, 2019

CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT CARELINK REPORTS GUIDE

Objectives. Glucose Monitoring Today. Tracking Glucose ISO Standards. Continuous Glucose Monitoring & Diabetes Management 3/7/2015

DEMYSTIFYING INSULIN THERAPY

Hybrid Closed Loop Status & Practical Challenges in Implementation

CareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes

Introducing DEXCOM STUDIO INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT

Transcription:

Using and Interpreting Diabetes Data Irl B. Hirsch, MD University of Washington

Dualities Research: Helmsely Charitable Trust, ADA, JDRF, NIDDK Consulting: Abbott Diabetes Care, Roche, Intarcia, Valeritas, Adocia, Big Foot And if you still don t trust me I will be happy to share my tax forms with you

Raise Your Hand If In Your Practice Every patient gets their meter downloaded Every patient gets their pump downloaded Every patient gets their CGM downloaded No patient gets downloaded, but you encourage your patients to download at home If you have at least one computer designated for downloading If your downloads are uploaded into your EMR

What You Need (Minimal) A program which allows downloading of various meters/pumps/sensors Clinipro (Numedics.com), Glooko/Diasend, Carelink, Tidepool Ideally, many of the native softwares are also available A better solution: immediate upload to the cloud Livongo, Accucheck Aviva Connect, Dexcom Clarity

Glucometrics Analysis of blood glucose data To better understand the glycemic fingerprint of each individual patient: A1C, mean, SD, CV, TIR, LBGI

Standard Deviation Our clinically available measurement of glycemic variability for both SMBG and CGM Many other statistical analysis are available but correlation will be with CGM and outcomes, not SMBG (current studies and new consensus using CV) Can determine both overall and time specific SD SMBG: I prefer a month of data for less potential bias/outliers CGM: 2 weeks is fine

Calculation To Determine SD Target SMBG SD X 3 < MEAN SD X 2 < mean, may be difficult for some type 1 patients. Formulas only relevant for mean BG between 120-180 CGM SD X 3 < MEAN Better metrics: CV, TIR, TBR, TAR all to be correlated with outcomes

Example: Patrick Read aggregate mean/sd Note frequency of testing Note time-specific mean/sd

https://www.diabetestechnology.org/surveillance.shtml Accessed August 18, 2017 N = 1035 for the latest ISO standard (ISO15197-2013)

ONE Reason Why Downloading Is So Important: Understanding the Mean and Estimated A1C 24 year-old woman, MDI, using Dexcom, 14 years T1D This patient s HbA1c is 8.2%. She has a glycation gap due to iron deficiency anemia

Hematologic conditions Anemia Accelerated erythrocyte Thalassemia Sickle cell disease Reticulocytosis Hemolysis Physiologic States Aging Pregnancy Drugs/Medications Alcohol Opioids Vitamin C Vitamin E Aspirin Erythropoetin Dapsone Ribavirin What Alters A1C turnover Disease States HIV infection Uremia Hyperbilirubinemia Dyslipidemia Cirrhosis Hypothyroidism* Medical Therapies Blood transfusion Hemodialysis In a typical diabetes practice, 14%-25% of A1C measurements are Miscellaneous misleading Glycation rate Protein turnover Race and ethnicity* Laboratory assay Glycemic Variability Smoking Mechanical heart valves Exogenous testosterone?

CASE 2 45 y/o Ethiopian man moved to Seattle to work as an executive for a coffee company (we don t have Dunkin Donuts in Seattle) T2DM X 10 years, on insulin X8 years BMI 36; A1C 8.7% Has been on SAP for 4 years

SEPT 2014:MEAN 197; SD 75; A1C = 8.7%

Good basal BC: 17U BC: 11.5 U 60 g CHO 44 g CHO Stayed high: last bolus not enough No bolus: too much basal? Insulin given with food Insulin given with food

With All of This Technology, His Major Problem is Easy (or Should Be) to Fix Insulin needs to be given before one eats! Why is this so difficult for so many patients?

So What Happened To Our Patient s Diabetes Over the Next Two Years? OCT 2016: Mean = 156; SD = 41; A1C = 7.1%

CASE 3: 20 y/o T1D, Down Syndrome T1D X 11 years, CSII and CGM. Last SH 5 years ago; HbA1c 7.6%

High basals in the evening do help to cushion dinner but usually result in hypoglycemia if not snacking. Timing of nocturnal basal change is important! Hypoglycemic seizure at 1:30am. Why?

CASE 4-Other Downloading Options 44 y/o woman, T1D X 22 years, using Omnipod and Dexcom Frustrated with downloading choices Decided to try Tidepool (Tidepool.org) Last HbA1c 6.8%

Blip CGM SMBG Toggle cursor: 29 g carb, suggested bolus 2.4 u, delivered 1.7 u Ouch!

Case 8a: Twin Sister! Dexcom, No Pump Most variability after breakfast and bedtime Highest average after lunch

BAD DAY Move the cursor

GOOD DAY

CASE 5 60 y/o woman, 41 years T1D using Animas Vibe Past history significant for PDR s/p PRP, DAN with gastroparesis After many years of no diagnosis, found in 2010 to have stiffperson s syndrome HbA1c prior to SPS Dx usually in the 7-8% range, after Dx most in 9-11% range. 75-80% of total daily insulin is basal insulin What s going on?

Case 5: AGP from 60 y/o Woman with SPS Feb 2016, HbA1c 10.1% h

CASE 5: The Answer to the Problem (but you need the download!) No bolus

Case 6 : 59 y/o Man, CSII Without CGM T1D x 21 years, CSII X 10 years, last seen by an endocrinologist more than 15 years ago Referred by concerned family member due to firstever severe hypoglycemia No interest in CGM HbA1c ranges 8 to 9.2%, most recent 8.5% First visit: 2-3 tests per day, mean/sd 202/85 Where to start?

Type 1 Diabetes, August, 2017: Where to Start? Only checking 2, at most 3X s per day, blind boluses, minimal use of bolus calculator, asymptomatic hypoglycemia. Where to start? WHAT I DID: BRING IN WIFE, ENCOURAGE CGM OR AT LEAST MORE FREQUENT SMBG, LOOK AT INSULIN DOSES!

Part of the Problem Too many basal doses, and they don t make any sense! Total basal is 27% of total daily insulin dose with losest dose between 9am to 3:30pm

Important Point In the US, about 30% of our type 1 patients use CSII (60% in the T1D Exchange) and most agree the majority of adult type 1 patients receive their care by nonendocrinologists (one recent estimate was that 2/3 of T1D is only seen by primary care) The majority of patients use MDI-will closed loop systems increase CSII use for those who are cared for by both endocrinologists and non-specialists? DIAMOND and GOLD studies (JAMA, 2017): outcomes improved with CGM and MDI

What About the 70% of T1D Who Use MDI? Companion Medical InPen system Approved by FDA 8/16, to be launched 2017 (?) Will track prandial insulin doses (cartridge pens) and send to paired app via Bluetooth App also includes a bolus calculator (with real-time IOB) Many other companies working on these bluetooth enabled insulin pens

What does it look like?

Sensors: Continual Evolution For the Near Future Guardian Sensor 3 Freestyle Libre Glysense Implantable Sensor Raise you hand if you use the FreeStyle Libre Pro routinely in your practice? Dexcom Gen 6 Sensionics Implantable Sensor

What s Going On? 85 y/o man, no cognitive concerns, changed 5 years ago to multiple injections from 70/30 premix Mean/SD on glucose testing at home 185/60 testing 2.5 times daily on meter first started to use 18 months ago HbA1c now 11.8% What to do?

No glycation gap! Not enough blood on new CMS meter, readings consistently low when compared to FGM

Fingerstick BG 95 162 188

Sometimes the FLP Gives Us TMI 32 y/o woman with 14 years T1D, divorced for 1 year. Works as a commercial realtor. No children On MDI, stopped CGM as it inhibits my social life Agreed to wear FLP for 14 days Conclusion?

NPH Insulin in 2017 45 y/o man who still had insulin lispro and a few CGMs from last year. Deductable is $4000 and can t afford list price of glargine (let alone degludec), so he simply used NPH instead. His A1C is 6.9% NPH isn t so bad if you know how to use it!

NPH and Regular, August 2017 55 y/o man, T1D for more than 40 years. Can t afford analogue insulin

Raise Your Hand if You Have Patients on Our First Hybrid Closed Loop? Patient still needs to bolus for meals and notify the system for exercise. Won t be for everyone-many love it, others don t want the extra burden on their diabetes, yet others don t find it aggressive enough.

Key Pearls for 670G for Hybrid Closed Loop Patients HAVE to use bolus calculator for auto mode to engage In auto mode, glycemia is maintained by changing basal doses Manual mode basal rates have no bearing in auto mode Meal doses: generally need higher doses (ICR), IOB 2-3 hours work best; algorithm determines auto basal, ISF, targets! Programmed manual mode ISF dose not apply in auto mode Calibration of CGM: 3-4 times daily

Conclusion Technology for MDI is finally improving, but still a lot of problems with SMBG accuracy and understanding of HbA1c Downloading should be part of the vital signs for every patient using a meter, pump, or sensor The downloading software is improving, is connected to the cloud, and should assist us in helping our patients How the endocrinologist can efficiently utilize all of this technology in our current system requires further research